Haemonetics Corp - Company Profile

Powered by

All the sales intelligence you need on Haemonetics Corp in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Haemonetics Corp fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Haemonetics Corp.

Back to companies

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Haemonetics Corp’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Haemonetics Corp's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Ellen M. Zane

Chairman Executive Board Since: 2018 Age: 74

Ms. Ellen Zane has been the Chairman of the company since 2021. Prior to this, she served as the Chief Executive Officer Emeritus of Tufts Medical Center and Tufts Children's Hospital, as President and Chief Executive Officer from 2004 to 2011. Before that, she served as the Network President for Partners Healthcare System and and as Chief Executive Officer of Quincy Hospital in Quincy. Previously, he served as the director of Haemonetics from 2012 to 2016.

Read Hide full bio of Ellen M. Zane

Christopher A. Simon

Director; Chief Executive Officer; President Executive Board Since: 2016 Age: 62

Mr. Christopher Simon has been the Chief Executive Officer, President, and a Director of the Board of the company since 2016. Prior to this role he served as the Lead Partner at McKinsey & Company's current strategy review from 1993 to 2016. Previously, he served in several commercial roles at Baxter Healthcare Corporation. Currently, he serves as the Simon also serves as the Director of AdvaMed.

Read Hide full bio of Christopher A. Simon

James C. D’Arecca

Chief Financial Officer; Executive Vice President Senior Management Since: 2022 Age: 55

Mr. James D’Arecca has been the Executive Vice President, Chief Financial Officer and Principal Financial Officer of the company since April 2022. Prior to this, he served as the Chief Financial Officer of TherapeuticsMD. Previously, he served as the Senior Vice President and Chief Accounting Officer of Allergen plc and Chief Accounting Officer at Bausch & Lomb. He also served in various roles at Merck & Co., Inc. and Schering-Plough Corporation.

Read Hide full bio of James C. D’Arecca

Frank W. Chan, Ph.D.

Chief Operating Officer; Executive Vice President Senior Management Since: 2025 Age: 56

Mr. Frank Chan has been the Executive Vice President and Chief Operating Officer of the company since April 2025. Previously, he was the President of Acute Care & Monitoring at Medtronic plc. He also served at commercial, operational and technical leadership positions across multiple businesses at Medtronic plc from 2015 to April 2025. Mr. Chan also held various leadership positions including research and development and medical affairs at Covidien plc from 2011 to 2015.

Read Hide full bio of Frank W. Chan, Ph.D.

Jan Hartmann, M.D.

Chief Medical Officer; Senior Vice President Senior Management Since: 2023

Mr. Jan Hartmann, M.D. has been the Senior Vice President, Chief Medical Officer in 2023. Prior to this, he served as the Associate Partner at McKinsey & Company.

Read Hide full bio of Jan Hartmann, M.D.
Gain a 360-degree view of Haemonetics Corp and make more informed decisions for your business Gain a 360-degree view of Haemonetics Corp and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer